- Home
- GOOD vs EOLS Comparison
GOOD vs EOLS Comparison
Compare GOOD & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOOD | EOLS |
|---|---|---|
| Founded | 2003 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 624.9M | 529.1M |
| IPO Year | 2003 | 2018 |
Fundamental Metrics
Financial Performance| Metric | GOOD | EOLS |
|---|---|---|
| Price | $12.74 | $7.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $14.13 | ★ $15.00 |
| AVG Volume (30 Days) | 314.5K | ★ 613.8K |
| Earning Date | 11-02-2026 | 11-04-2026 |
| Dividend Yield | ★ 9.51% | N/A |
| EPS Growth | N/A | ★ 1.23 |
| EPS | ★ 0.18 | N/A |
| Revenue | $161,336,000.00 | ★ $297,176,000.00 |
| Revenue This Year | $5.94 | $12.44 |
| Revenue Next Year | $3.02 | $17.37 |
| P/E Ratio | $70.28 | ★ N/A |
| Revenue Growth | 8.00 | ★ 11.61 |
| 52 Week Low | $10.33 | $3.86 |
| 52 Week High | $13.28 | $9.31 |
Technical Indicators
Market Signals| Indicator | GOOD | EOLS |
|---|---|---|
| Relative Strength Index (RSI) | 39.45 | 45.13 |
| Support Level | $12.23 | $7.59 |
| Resistance Level | $12.92 | $8.47 |
| Average True Range (ATR) | 0.20 | 0.29 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 13.28 | 29.89 |
Price Performance
Historical ComparisonAbout GOOD Gladstone Commercial Corporation Real Estate Investment Trust
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.
About EOLS Evolus Inc.
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.